| 摘要 |
Stabilised compsn. comprises an organic substrate (I), subject to degradation by oxidn. and/or free radicals, with a stabilising amt. of inositoltriphosphate (IP3). Substrate (I) may be a pharmaceutical or biological system, pref. insulin, a vaccine, hyaluronic acid, intralipid, prostaglandin, nucleic acid, carbohydrate, lipid or protein (e.g. enzyme, microorganism, plant part, seed, etc.). Minor amts. of inostol tetraphosphate (IP4) and -diphosphate (IP2) may also be present. |
